On March 18, 2024, SymBio Pharmaceuticals Limited closed the transaction. The company amended the terms of the transaction and issued 1,350,000 common shares at an issue price of ¥190 per share for the gross proceeds of ¥256,500,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
175 JPY | -1.69% | +0.57% | -29.15% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.15% | 50.92M | |
+25.61% | 661B | |
+26.74% | 566B | |
-6.64% | 352B | |
+19.42% | 332B | |
+3.49% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.54% | 145B |
- Stock Market
- Equities
- 4582 Stock
- News SymBio Pharmaceuticals Limited
- SymBio Pharmaceuticals Limited amended terms of the transaction